Literature DB >> 33356253

Tuning the Biological Activity of RGD Peptides with Halotryptophans†.

Isabell Kemker1, David C Schröder1, Rebecca C Feiner2, Kristian M Müller2, Antoine Marion3, Norbert Sewald1,3.   

Abstract

An array of l- and d-halotryptophans with different substituents at the indole moiety was synthesized employing either enzymatic halogenation by halogenases or incorporation of haloindoles using tryptophan synthase. Introduction of these Trp derivatives into RGD peptides as a benchmark system was performed to investigate their influence on bioactivity. Halotryptophan-containing RGD peptides display increased affinity toward integrin αvβ3 and enhanced selectivity over integrin α5β1. In addition, bromotryptophan was exploited as a platform for late-stage diversification by Suzuki-Miyaura cross-coupling (SMC), resulting in new-to-nature biaryl motifs. These peptides show enhanced affinity toward αvβ3, good affinity to αvβ8, and remarkable selectivity over α5β1 and αIIbβ3 while featuring fluorogenic properties. Their feasibility as a probe was demonstrated in vitro. Extensive molecular dynamics simulations were undertaken to elucidate NMR and high-performance liquid chromatography (HPLC) data for these late-stage diversified cyclic RGD peptides and to further characterize their conformational preferences.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33356253     DOI: 10.1021/acs.jmedchem.0c01536

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

Review 1.  Natural and Synthetic Halogenated Amino Acids-Structural and Bioactive Features in Antimicrobial Peptides and Peptidomimetics.

Authors:  Mario Mardirossian; Marina Rubini; Mauro F A Adamo; Marco Scocchi; Michele Saviano; Alessandro Tossi; Renato Gennaro; Andrea Caporale
Journal:  Molecules       Date:  2021-12-06       Impact factor: 4.411

2.  Synthesis and Evaluation of a Non-Peptide Small-Molecule Drug Conjugate Targeting Integrin αVβ3.

Authors:  Jannik Paulus; Norbert Sewald
Journal:  Front Chem       Date:  2022-04-11       Impact factor: 5.545

Review 3.  Peptide therapeutics in the management of metastatic cancers.

Authors:  Debopriya Bose; Laboni Roy; Subhrangsu Chatterjee
Journal:  RSC Adv       Date:  2022-08-02       Impact factor: 4.036

4.  Peptide stapling by late-stage Suzuki-Miyaura cross-coupling.

Authors:  Rebecca C Feiner; Ridhiwan Mseya; Hendrik Gruß; David C Schröder; Michał Jewgiński; Kristian M Müller; Rafał Latajka; Antoine Marion; Norbert Sewald
Journal:  Beilstein J Org Chem       Date:  2022-01-03       Impact factor: 2.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.